During the past decade, Hospital Nacional Edgardo Rebagliati Martins; Servicio de Reumatología conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 1 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Nacional Edgardo Rebagliati Martins; Servicio de Reumatología" #1 collaborator was "Roche Pharma AG" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Hospital Nacional Edgardo Rebagliati Martins; Servicio de Reumatología" are "Lupus Nephritis" (1 trials) and "Rheumatoid Arthritis" (1 trials). Many other conditions were trialed in "Hospital Nacional Edgardo Rebagliati Martins; Servicio de Reumatología" in a lesser frequency.

Most popular intervention types in "Hospital Nacional Edgardo Rebagliati Martins; Servicio de Reumatología" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Acetaminophen" (1 trials), "Diphenhydramine" (1 trials), "Leflunomide" (1 trials) and "MMF" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Nacional Edgardo Rebagliati Martins; Servicio de Reumatología" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Hospital Nacional Edgardo Rebagliati Martins; Servicio de Reumatología". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Hospital Nacional Edgardo Rebagliati Martins; Servicio de Reumatología, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Nacional Edgardo Rebagliati Martins; Servicio de Reumatología, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".